ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -

return kwic search for who out of >500 occurrences
271863 occurrences (No.95 in the rank) during 5 years in the PubMed. [cache]
95) Cardiometabolic, clinical and quality-of-life (QoL) measures were assessed before and after etanercept treatment in patients who had moderate-to-severe plaque psoriasis with and without psoriatic arthritis (PsA) in the PRISTINE trial.
--- ABSTRACT ---
PMID:24283931 DOI:10.3109/09546634.2013.860209
2015 The Journal of dermatological treatment
* Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis.
- Cardiometabolic, clinical and quality-of-life (QoL) measures were assessed before and after etanercept treatment in patients who had moderate-to-severe plaque psoriasis with and without psoriatic arthritis (PsA) in the PRISTINE trial. Adult patients were randomized to receive etanercept 50 mg once weekly or twice weekly double-blind for 12 weeks; all patients subsequently received etanercept 50 mg once weekly open-label through week 24. Metabolic syndrome was identified in 44 and 41% of patients with and without PsA, elevated blood pressure in 73 and 56% (p<0.05) and diabetes in 21 and 9% (p<0.01), respectively. Significant improvements from baseline in Psoriasis Area Severity Index were observed with etanercept therapy at all time points over 24 weeks (p<0.001) independent of PsA history. At baseline, patients with PsA had worse QoL than patients without PsA. After 24 weeks of etanercept, both groups had significant improvement from baseline in QoL, but the PsA group had greater improvement than that without PsA. Cardiovascular comorbidities were common in psoriasis patients with and without PsA, suggesting that clinicians need to be attentive to cardiometabolic parameters in this population. Worse QoL was demonstrated in PsA versus psoriasis alone. Regardless of patients' PsA status, treatment with etanercept significantly improved skin symptoms and QoL measures.
--- ABSTRACT END ---
[
right
kwic]
[frequency of next (right) word to who]
(1)62 were (15)5 participated (29)2 Basic (43)2 read
(2)53 had (16)5 sexually (30)2 believed (44)2 require
(3)25 are (17)4 do (31)2 can (45)2 required
(4)25 have (18)4 is (32)2 commuted (46)2 scored
(5)25 underwent (19)4 responded (33)2 consumed (47)2 showed
(6)21 received (20)4 sought (34)2 deal (48)2 smoked
(7)14 presented (21)3 attended (35)2 died (49)2 struggle
(8)13 developed (22)3 has (36)2 experience (50)2 suffered
(9)11 reported (23)3 in (37)2 had, (51)2 sustained
(10)11 was (24)3 lived (38)2 live (52)2 took
(11)10 completed (25)3 may (39)2 lives (53)2 use
(12)10 experienced (26)3 met (40)2 measured (54)2 wanted
(13)8 did (27)3 work (41)2 participate
(14)5 inject (28)3 would (42)2 present

add keyword

--- WordNet output for who --- =>だれ, だれが, だれを, する(人), そしてその人は, 世界保健機構 Overview of noun who The noun who has 1 sense (no senses from tagged texts) 1. World Health Organization, WHO -- (a United Nations agency to coordinate international health activities and to help governments improve health services) --- WordNet end ---